ReShape Lifesciences Inc. (RSLS)
undefined
undefined%
At close: undefined
4.52
-4.44%
After-hours Dec 13, 2024, 04:12 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -11.39M -46.21M -61.93M -21.63M -74.21M -35.27M -33.82M -23.36M -25.50M -26.13M -25.78M -23.46M -26.00M -17.35M -31.93M -37.87M -28.58M -17.69M -11.22M
Depreciation & Amortization 154.00K 2.15M 1.97M 1.67M 1.71M 440.56K 925.46K 139.58K 188.61K 188.90K 174.63K 226.99K 303.97K 375.76K 424.35K 513.06K 992.37K 95.85K 143.23K
Stock-Based Compensation 766.00K 2.09M 12.23M 1.32M 2.31M 3.10M 4.44M 2.33M 6.94M 6.32M 5.95M 4.23M 2.89M 2.56M 2.44M 2.52M - - -
Other Working Capital -337.00K 770.00K -608.00K 929.00K -1.14M -929.62K 1.58M 960.24K -783.20K -316.33K 787.12K -3.20M -176.99K 571.10K -659.00K 698.87K -11.07K 1.21M 768.83K
Other Non-Cash Items -2.39M 19.79M 34.64M 10.17M 58.56M 6.83M 4.73M -3.51M -3.30M 6.44M 8.03K 4.44M -26.00M -158.83K 3.64M 3.17M 4.23M 157.81K 25.04K
Deferred Income Tax 28.00K -423.00K -60.00K -86.00K -1.14M -3.45M -2.31M 1.86M 826.62K -6.32M 199.59K -4.22M 26.24M 440.48K 1.50M -2.52M - - -
Change in Working Capital -4.13M 709.00K -2.74M 6.00K -1.43M 857.22K 1.45M 1.89M -1.77M 113.38K 1.02M -3.68M 2.63M 461.15K -732.71K 515.83K -11.07K 1.21M 768.83K
Operating Cash Flow -16.96M -21.90M -15.38M -8.55M -14.20M -27.49M -24.59M -20.66M -22.61M -19.38M -18.43M -22.48M -19.94M -13.66M -24.66M -33.67M -23.37M -16.23M -10.28M
Capital Expenditures -43.00K -131.00K -352.00K -390.00K -14.00K -49.58K -137.12K -14.00K -38.91K -88.68K -416.01K -76.39K -252.27K -2.59K -186.98K -244.44K -800.39K -634.97K -449.81K
Acquisitions - 39.00K 2.21M -2.00M -2.00M -10.28M -6.23M - 6.00K - - - - - - - - - -
Purchase of Investments - -39.00K - - - -9.10M -94.61M -18.90M -18.59M - - - -5.01M - - -10.31M -6.94M -20.04M -
Sales Maturities Of Investments - 639.00K - - 2.55M 29.90M 73.80M 25.45M 21.50M - - 1.00M 4.00M - 5.23M 13.39M 15.99M 3.00M -
Other Investing Acitivies 33.00K -600.00K 2.21M - -2.55M -20.80M 20.81M -6.55M - - 200.00K 1.00M 6.33M -6.53M - - - - -
Investing Cash Flow -10.00K -92.00K 1.85M -2.39M -2.01M -10.33M -6.37M -14.00K -38.91K -88.68K -216.01K 923.61K 5.07M -6.53M 5.04M 2.83M 8.25M -17.67M -449.81K
Debt Repayment - - -9.50M 10.46M - - - 16.80M 5.00M -4.00M -3.00M 4.59M -922.00K -1.89M -6.78M 3.33M 7.21M 1.34M 8.38M
Common Stock Repurchased - - - - - - - - - - - - -1.21M -2.60M -898.97K - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies 17.57M 2.49M 42.80M 620.00K 13.18M -4.54M 31.34M -749.79K -8.70M 1.96M -1.42M 5.73M -1.08M 5.80M 20.86M -164.83K -1.75M -1.49M -40.05K
Financial Cash Flow 17.57M 3.13M 33.30M 11.07M 13.66M 33.20M 37.81M 16.05M 18.95M 7.79M 19.63M 15.38M 12.52M 36.42M 13.18M 3.16M 46.32M 40.72M 16.11M
Net Cash Flow 604.00K -18.86M 19.81M 22.00K -2.56M -4.62M 6.85M -4.62M -3.69M -11.68M 988.70K -6.18M -2.35M 16.22M -6.44M -27.68M 31.20M 6.82M 5.39M
Free Cash Flow -17.00M -22.03M -15.73M -8.94M -14.21M -27.54M -24.73M -20.67M -22.64M -19.47M -18.84M -22.56M -20.19M -13.67M -24.84M -33.91M -24.17M -16.86M -10.73M